These findings improve our understanding of CTRP9 of different cell origins in regulating cardiomyocyte apoptosis after MI/R injury, and suggest the potential value of therapeutic approaches targeting cardiac-derived CTRP9 or CRT in the treatment and prevention IHD and its complications. The gene discussed is C1QTNF9; the disease is myocardial infarction.